Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Multiple Pulmonary Nodules 1Lung Neoplasms 1Liver Neoplasms 1Hemorrhage 1Blood Loss, Surgical 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuromuscular Blockade × 1 year × Clear all
NCT07395375 2026-02-09

NIVA-TSLR

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
1,600 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

NCT04609410 2025-08-07

MODELS

Università Vita-Salute San Raffaele

Phase NA Terminated
48 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon âš¡